{
    "clinical_study": {
        "@rank": "156283", 
        "acronym": "PR-PROS", 
        "arm_group": {
            "arm_group_label": "male adults (age > 18 y/o) with prostate cancer", 
            "description": "Men received radiosurgery for clinically localized prostate cancer"
        }, 
        "brief_summary": {
            "textblock": "Quality of life data following SBRT for prostate cancer has been obtained in only a small\n      numbers of patients.  A prospective study using validated quality of life questionnaires is\n      needed to determine outcomes after treatment with SBRT.  Our study will be the first\n      essential step in developing a better evidence base on the comparative risks and benefits of\n      SBRT treatment with regards to quality of life assessment and outcomes."
        }, 
        "brief_title": "Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery", 
        "condition": "Clinically Localized Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Study Design (for example, hypothesis, research question, standard and experimental\n      procedures, special or unusual equipment or procedures):\n\n      The main goal of this study is to evaluate quality of life outcomes and changes in patient\n      reported symptoms (e.g. urinary, bowel and sexual function) in patients receiving SBRT\n      treatment for clinically localized prostate cancer.  Validated quality of life\n      questionnaires will be administered in a deidentified, prospective fashion.  Eligible\n      subjects will be patients undergoing SBRT treatment for prostate cancer.\n\n      Hypothesis: Patients undergoing SBRT will have similar cancer control and symptoms as men\n      who are treated with other radiation therapy modalities.\n\n      Primary objective:  To evaluate quality of life outcomes (e.g. fatigue, urinary, bowel and\n      sexual function) for patients with clinically localized prostate cancer treated with SBRT.\n\n      Secondary objectives: Prospective data on cancer control and toxicity following SBRT for\n      clinically localized prostate cancer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed adenocarcinoma of prostate\n\n          -  Signed study-specific consent\n\n          -  PSA within 60 days of registration\n\n        Exclusion Criteria:\n\n          -  Prior pelvic radiotherapy\n\n          -  Prior radical prostate surgery\n\n          -  Medical or psychiatric illness that would interfere with treatment or follow up\n\n          -  Implanted hardware adjacent to the prostate that would prohibit appropriate treatment\n             planning and/or treatment delivery"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Men (> 18 y/o) with clinically localized prostate cancer,"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01766492", 
            "org_study_id": "2012-1175"
        }, 
        "intervention": {
            "arm_group_label": "male adults (age > 18 y/o) with prostate cancer", 
            "intervention_name": "Stereotactic Body Radiation Therapy (SBRT)", 
            "intervention_type": "Radiation", 
            "other_name": "CyberKnife radiosurgery"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prostate cancer", 
            "CyberKnife"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "email": "leonard.n.chen@gunet.georgetown.edu", 
                "last_name": "Leonard N Chen, MD,PhD", 
                "phone": "202-444-3068"
            }, 
            "contact_backup": {
                "email": "spc9@gunet.georgetown.edu", 
                "last_name": "Sean P Collins, MD, PhD", 
                "phone": "202-444-3292"
            }, 
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20007"
                }, 
                "name": "Georgetown University Hospital"
            }, 
            "investigator": {
                "last_name": "Sean P Collins, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)", 
        "overall_contact": {
            "email": "leonard.n.chen@gunet.georgetown.edu", 
            "last_name": "Leonard Chen, MD, PhD", 
            "phone": "202-444-3068"
        }, 
        "overall_contact_backup": {
            "email": "spc9@gunet.georgetown.edu", 
            "last_name": "Sean P Collins, MD, PhD", 
            "phone": "202-444-3292"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Use questionnaire to assess patient's symptoms regarding fatigue", 
                "measure": "fatigue", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Use questionnaire to assess patient's symptoms regarding urinary symptoms after radiosurgery", 
                "measure": "urinary symptoms", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "description": "Use questionnaire to assess patient's symptoms regarding bowel symptoms after radiosurgery", 
                "measure": "bowel symptoms", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "description": "Use questionnaire to assess patient's symptoms regarding sexual symptoms after radiosurgery", 
                "measure": "sexual function", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }
        ], 
        "reference": {
            "PMID": "17482880", 
            "citation": "Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Huddart RA, Jose CC, Matthews JH, Millar J, Moore AR, Morgan RC, Russell JM, Scrase CD, Stephens RJ, Syndikus I, Parmar MK; on behalf of the RT01 collaborators. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007 May 4; [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01766492"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "clinical evidence of localized and distal cancer controls", 
                "measure": "cancer control", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "description": "Evaluate all the treatment-related toxicity by both clinical evidence(physical exam and lab) and quality of life questionnaire", 
                "measure": "toxicity", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }
        ], 
        "source": "Georgetown University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Georgetown University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}